{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:14:01Z","timestamp":1792840441880,"version":"4.5.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020732","name":"Innovative research team of high-level local universities in Shanghai","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Renal involvement in chronic lymphocytic leukemia (CLL) is uncommon but can lead to significant morbidity. Membranoproliferative glomerulonephritis (MPGN) is among the most frequently reported glomerular lesions associated with CLL and may presents with nephrotic syndrome. Early recognition of the association between renal lesions and CLL is crucial for guiding treatment and improving both renal and hematologic outcomes. We report two biopsy-proven cases of CLL-associated MPGN successfully treated with next-generation Bruton\u2019s tyrosine kinase inhibitors (BTKis). Both patients presented with nephrotic-range proteinuria. In Case 1, the patient exhibited monoclonal IgG-\u03ba gammopathy and isolated low serum C3, suggestive of complement-mediated injury without direct immunoglobulin deposition. He achieved sustained hematologic and renal remission with orelabrutinib following early discontinuation of rituximab\u2013chlorambucil due to infection. In Case 2, renal biopsy showed interstitial infiltration by CLL cells and immune complex deposition, supporting a leukemic infiltration and immune-complex mediated mechanism. Zanubrutinib led to clinical improvement, and rituximab was later added to further reduce proteinuria. These cases underscore the critical role of kidney biopsy in clarifying diagnosis and underlying mechanisms. In this case series, the treatment regimen centered on next-generation BTKis enabled patients to achieve concurrent favorable renal and hematologic remission with good tolerability.<\/jats:p>","DOI":"10.1007\/s00277-026-06730-w","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:55:29Z","timestamp":1769734529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Next-generation Bruton\u2019s tyrosine kinase inhibitors for chronic lymphocytic leukemia-associated membranoproliferative glomerulonephritis: a case report"],"prefix":"10.1007","volume":"105","author":[{"given":"Li","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanli","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Qing","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"25","key":"6730_CR1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating M, Montserrat E, Chiorazzi N, Stilgenbauer S, Rai KR, Byrd JC, Eichhorst B, O\u2019Brien S, Robak T, Seymour JF, Kipps TJ (2018) IwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 131(25):2745\u20132760. https:\/\/doi.org\/10.1182\/blood-2017-09-806398","journal-title":"Blood"},{"issue":"9","key":"6730_CR2","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3324\/haematol.2015.128793","volume":"100","author":"P Strati","year":"2015","unstructured":"Strati P, Nasr SH, Leung N, Hanson CA, Chaffee KG, Schwager SM, Achenbach SJ, Call TG, Parikh SA, Ding W, Kay NE, Shanafelt TD (2015) Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo clinic experience. Haematologica 100(9):1180\u20131188. https:\/\/doi.org\/10.3324\/haematol.2015.128793","journal-title":"Haematologica"},{"issue":"2","key":"6730_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/003130201201117945","volume":"34","author":"PA Hill","year":"2002","unstructured":"Hill PA, Firkin F, Dwyer KM, Lee P, Murphy BF (2002) Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: a report of three cases. Pathology 34(2):138\u2013143. https:\/\/doi.org\/10.1080\/003130201201117945","journal-title":"Pathology"},{"issue":"12","key":"6730_CR4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMra1108178","volume":"366","author":"S Sethi","year":"2012","unstructured":"Sethi S, Fervenza FC (2012) Membranoproliferative glomerulonephritis\u2013a new look at an old entity. N Engl J Med 366(12):1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMra1108178","journal-title":"N Engl J Med"},{"issue":"3","key":"6730_CR5","doi-asserted-by":"publisher","first-page":"e0119156","DOI":"10.1371\/journal.pone.0119156","volume":"10","author":"AL Poitou-Verkinder","year":"2015","unstructured":"Poitou-Verkinder AL, Francois A, Drieux F, Lepretre S, Legallicier B, Moulin B, Godin M, Guerrot D (2015) The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia \/ small lymphocytic lymphoma: a 25-year multicenter experience. PLoS ONE 10(3):e0119156. https:\/\/doi.org\/10.1371\/journal.pone.0119156","journal-title":"PLoS ONE"},{"issue":"5","key":"6730_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ckj\/sfy026","volume":"11","author":"R Wanchoo","year":"2018","unstructured":"Wanchoo R, Bernabe Ramirez C, Barrientos J, Jhaveri KD (2018) Renal involvement in chronic lymphocytic leukemia. Clin Kidney J 11(5):670\u2013680. https:\/\/doi.org\/10.1093\/ckj\/sfy026","journal-title":"Clin Kidney J"},{"issue":"4S","key":"6730_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"G Work","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes Glomerular Diseases, Work G (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100(4S):S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"},{"issue":"22","key":"6730_CR8","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","volume":"120","author":"N Leung","year":"2012","unstructured":"Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, Dispenzieri A, Song KW, Kyle RA, International K, Monoclonal Gammopathy Research G (2012) Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood 120(22):4292\u20134295. https:\/\/doi.org\/10.1182\/blood-2012-07-445304","journal-title":"Blood"},{"issue":"4","key":"6730_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJMoa2211582","volume":"388","author":"JR Brown","year":"2023","unstructured":"Brown JR, Eichhorst B, Hillmen P, Jurczak W, Kazmierczak M, Lamanna N, O\u2019Brien SM, Tam CS, Qiu L, Zhou K, Simkovic M, Mayer J, Gillespie-Twardy A, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Osterborg A, Yimer HA, Salmi T, Wang MD, Fu L, Li J, Wu K, Cohen A, Shadman M (2023) Zanubrutinib or ibrutinib in relapsed or refractory chronic lymphocytic leukemia. N Engl J Med 388(4):319\u2013332. https:\/\/doi.org\/10.1056\/NEJMoa2211582","journal-title":"N Engl J Med"},{"issue":"4","key":"6730_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/ajh.26826","volume":"98","author":"W Xu","year":"2023","unstructured":"Xu W, Zhou K, Wang T, Yang S, Liu L, Hu Y, Zhang W, Ding K, Zhou J, Gao S, Xu B, Zhu Z, Liu T, Zhang H, Hu J, Ji C, Wang S, Xia Z, Wang X, Li Y, Song Y, Ma S, Tang X, Zhang B, Li J (2023) Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia\/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. Am J Hematol 98(4):571\u2013579. https:\/\/doi.org\/10.1002\/ajh.26826","journal-title":"Am J Hematol"},{"issue":"4","key":"6730_CR11","doi-asserted-by":"publisher","first-page":"e2062","DOI":"10.1002\/cnr2.2062","volume":"7","author":"N Danesin","year":"2024","unstructured":"Danesin N, Scapinello G, Del Prete D, Naso E, Berno T, Visentin A, Bonaldi L, Martines A, Bertorelle R, Vianello F, Gurrieri C, Zambello R, Castellani C, Fedrigo M, Rizzo S, Angelini A, Trentin L, Piazza F (2024) When Waldenstrom macroglobulinemia hits the kidney: description of a case series and management of a rare in rare scenario. Cancer Rep (Hoboken) 7(4):e2062. https:\/\/doi.org\/10.1002\/cnr2.2062","journal-title":"Cancer Rep (Hoboken)"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06730-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06730-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06730-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:22:06Z","timestamp":1781630526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06730-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":11,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["6730"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06730-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8195069\/v1","asserted-by":"object"}]},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Ruijin Hospital in Shanghai (Approval number 2025\u20132) and conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from both patients for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent to publish declaration"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}